New research found patients with certain head and neck cancers lived longer and experienced fewer side effects when treated ...

Combination therapy with nogapendekin alfa inbakicept and BCG achieved a 3-year DSS rate of 96% in BCG-unresponsive NMIBC ...

The survival rate among those with lung cancer has improved by more than a quarter in the last five years, according to a new report. Four years ago, the United States Preventive Services Task Force ...

Photon therapy offers strong outcomes in treating oropharyngeal cancers; however, some radiation can reach and damage nearby ...

ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...

Patients with advanced bladder cancer have significantly less risk of the disease progressing or returning when treated with an immunotherapy drug called durvalumab, research has shown. Jörg ...

Israeli researchers at a blood cancer conference in the US reported a lymphoma treatment that can achieve 100% survival rates ...

Being more physically active, following a balanced diet, not smoking, and keeping body weight and blood pressure under control: the same habits that protect the heart also prove decisive after a ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

Nearly one in 10 American adults now report having been diagnosed with cancer at some point in their lives—a notable jump from 7% in 2008-2009, according to the latest data from Gallup. Gallup says 9.

Targeted radioactive implants combined with chemotherapy are transforming inoperable pancreatic cancer into surgical ...